earnings
4.240 articole · RSS
Biofarm Emerges As Most Profitable Pharma Company On Bucharest Bourse
Biofarm (BIO.RO) was the most profitable pharmaceuticals company on the Bucharest stock exchange last year. Despite a two-percentage point drop in net profit margin to 15.5%, the drugmaker s...
BRD Net Profit Down 7% To RON465M In 2011
Romania’s second-largest lender BRD-Groupe Societe Generale (BRD.RO) Tuesday reported a net profit of 465 million lei (EUR109.7 million) for 2011, down 7% on the year, as the banking income...
Banca Transilvania 2011 Net Profit Up 35% To RON131.9M
Romanian lender Banca Transilvania (TLV.RO) Wednesday reported a preliminary net profit of 131.9 million lei (EUR31 million) for 2011, up 35% on the year, as provisioning costs fell, while n...
Azomures Net Profit Soars To RON288M In First 9 Months
Romanian chemical fertilizer maker Azomures (AZO.RO) Wednesday said its net profit more than tripled on the year to 288.2 million lei (EUR66.1 million) in the first nine months, fueled by a...
Prospectiuni 9-Month Net Profit Quadruples To RON30.7M
Romanian Prospectiuni Bucuresti (PRSN.RO), provider of geological surveys for the oil and gas industry, Monday reported a net profit of 30.7 million lei (EUR7.3 million) for January-Septembe...
Vae Apcarom Jan-Sep Net Profit Up 8% To RON5.2M
Romanian rolling stock maker Vae Apcarom Buzau (APC.RO), owned by Austria's Voestalpine, Thursday reported net profit of 5.2 million lei (EUR1.2 million) for the first nine months, up 8% on...
Price Decline And Higher Profits Make Shares Cheaper
Stocks on the regulated market of the Bucharest Stock Exchange (BVB) are on average 22% cheaper when measured against the profits made in the past year, compared with three months ago, follo...
Vrancart 1H Net Profit Drops 8% To RON1.5M
Romanian paper and cardboard maker Vrancart Adjud (VNC.RO) Friday reported a net profit of 1.5 million lei (EUR0.35 million) for the first six months, down 8% from RON1.66 million in the sam...
Antibiotice Iasi's 1H Pretax Profit Up 35% On Year
Romanian state-owned drugmaker Antibiotice Iasi (ATB.RO) reported a pretax profit of 28.2 million lei (EUR6.6 million) in the first half, up 35% on the year, the company said in a statement...